Asia’s Largest Web3 Event TOKEN2049 Singapore Announces Title Sponsors
7.6.2022 09:37:00 EEST | Business Wire | Press release
TOKEN2049, Asia’s premier crypto conference, has announced a number of high profile Title Sponsors for its much-anticipated Singapore debut. Taking place from 28-29 September 2022, this year’s event marks TOKEN2049’s first physical presence in Singapore, which will be held in conjunction with the Formula 1 Singapore Grand Prix 2022, ahead of the race weekend.
As the flagship event of Asia Crypto Week, the conference is set to see over 3,000 attendees as they gather to learn from prominent thought leaders and innovators across the crypto industry, including the CEOs and founders of some of the world’s largest crypto-related projects. Over 130 sponsors and exhibitors have already confirmed their participation with numbers steadily rising as anticipation builds ahead of September.
“TOKEN2049 is shaping up well in bringing together the brightest minds of our ecosystem in exploring pathways of innovation and collaboration. As one of the leading enablers dedicated to unlocking the full potential of digital assets, we look forward to the dialogue and conversations at this gathering,” said Cynthia Wu, Founding Partner at Matrixport.
With this year’s agenda spanning institutional investment trends to the rise of the metaverse and Web3, the diversity of this year’s title sponsors for TOKEN2049 Singapore is a testament to a flourishing industry ecosystem. This includes Singapore-based crypto unicorn and digital assets financial services platform Matrixport; leading cryptocurrency exchange app and Formula 1 global partner Crypto.com; global leader in digital assets products and infrastructure Amber Group; revolutionary social currency $WHALE which is backed by one of the largest and most valuable NFT collections in the world; community-governed DeFi platform MantraDAO; and collaborative Web3 credential infrastructure Project Galaxy.
Celebrating the upcoming event, Raphael Strauch, Founder of TOKEN2049 said: “Within the past few months, the crypto ecosystem has seen a whirlwind of change and growth, and it’s only befitting that we’re gathering in Singapore — one of the region’s leading innovation hubs — to celebrate how far we’ve come.”
Alongside its impressive speaker line-up including Pantera Capital CEO Dan Morehead, Ava Labs CEO Emin Gün Sirer, Three Arrows Capital CIO and CEO Su Zhu. Additional title sponsors at the event include enterprise-grade crypto infrastructure company Fireblocks; cryptocurrency exchange and derivative trading platform Bitmex; the EOS Network Foundation which is building a coordinated future for the EOS Network through decentralization and community; decentralised and open-source platform Syscoin; Asia’s leading institutional digital asset custodian Hextrust; global online identity verification platform Trulioo; the blockchain platform TRON and the first official Ethereum Virtual Machine based on the EOS network Trust EVM.
“From our decorated bench of Title Sponsors to our speaker line-up, we’re thrilled to see continued support from so many of the industry’s leading organizations and are looking forward to spotlighting some of the most exciting, emerging voices across the ecosystem. We’ve seen tremendous interest from potential speakers and sponsors alike, and are thrilled to deliver a top-notch conference experience for all. To that end, we are very excited to be hosting a large closing party CÉ LA VI Singapore, on the rooftop deck of the Marina Bay Sands, overlooking the F1 Grand Prix track, with several notable European DJs flying in to grace the event,” continued Strauch.
For more information and continued updates on TOKEN2049 Singapore, please visit: https://www.asia.token2049.com/
Raphael Strauch, Founder of TOKEN2049 is available for interview.
About TOKEN2049:
TOKEN2049 is a premier Web3 event, organised annually in Singapore and London, where decision-makers in the global crypto ecosystem connect to exchange ideas, network, and shape the industry. TOKEN2049 is a global meeting place for entrepreneurs, institutions, industry insiders, investors, and those with a strong interest in the crypto and blockchain industry.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220606006051/en/
Contact information
Media:
Melissa Esguerra
Senior Consultant
Wachsman
melissa.esguerra@wachsman.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 09:00:00 EEST | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This facility was secured prior to IQM’s recent announcement of plans to become the first publicly listed European quantum computing company through a merger with Real Asset Acquisition Corp (“RAAQ”). The facility lowers IQM’s overall cost of capital and improves the flexibility and diversity of its capital base. “The financing package comes at a pivotal time for IQM, as we build momen
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 08:45:00 EEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 02:35:00 EEST | Press release
Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Capability of Next Generation Earth Observation Satellites Project Title: Source-Specific CO2 Emission and Uptake Monitoring through Satellite Constellation and Ai
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom